Board of Directors
Pursuant to the Articles of Association of Bioretec, the company's Annual General Meeting elects a minimum of three (3) and a maximum of seven (7) board members. The term of office of members of the Board of Directors begins from the Annual General Meeting at which they are elected and expires at the end of the Annual General Meeting following the election.
In addition to the duties defined in laws and regulations and Bioretec's Articles of Association, the duties of Bioretec's Board of Directors include the following:
- to guide and supervise Bioretec's management and operations;
- to decide on significant matters pertaining to Bioretec's operations;
- to review and approve Bioretec's half-year reports, reports by the Board of Directors and financial statements;
- to approve Bioretec' strategy, business plans and certain Bioretec's policies and practices, as well as to supervise their application;
- to decide on significant business acquisitions, investments and divestments; and
- to define Bioretec's dividend policy.
Board committees add
Bioretec's Board of Directors has two permanent committees: the Audit Committee and the Nomination/Remuneration Committee, which assist the Board in the preparation of matters falling within its competence. The Board of Directors elects the members of these committees from among its members in connection with its annual constitutive meeting and supervises their work during the term of office.
- Current members of the Audit Committee are: Tomi Numminen, Sarah van Hellenberg Hubar-Fisher
- Current members of the Nomination/Remuneration Committee are: Michael Picciriollo, Päivi Malinen, Kustaa Poutiainen
Board of Directors
Tomi Numminen
Chairman of the Board of Directors
Chairman of the Board of Directors since 2019
Member of the Board since 2016
Member of the Audit Committee
Born 1971
Finnish citizen
Education: M.Sc. (Econ)
Background add
Main work experience:
- CEO of Bioretec 2016–2019
Positions of trust:
- Chairman of the Board of Uniogen Oy
- Injeq Oyj and Endicum Oy. During the five previous years, Numminen has served as a member of the Board of Directors of Labrox Oy, BBS-Bioactive Bone Substitutes Oyj, Aucor Oy ja Ocuspecto Oy.
Holdings in the company:
- 9,625,000 option rights entitling the subscription of 641,667 shares.
Not independent from the company, but independent from major shareholders
Sarah van Hellenberg Hubar-Fisher
Board member
Member of the Board since 2021
Member of the Audit Committee
Born 1978
Citizen of the United States and the Netherlands
Education: MBA, M.Sc Nutritional Epidemiology and Public Health
Background add
Main work experience:
- Global Public Health Financing Lead & MedTech External Innovation at Johnson & Johnson.
Position of Trust:
Supervisory Board roles: Global Surgical Initiatives (active), WillemPie (active), UVA Ventures (2020-2023).
Advisory Board roles: Nen.health Castor EDC, RespiQ. Venture Partner: Growth Science Ventures (2017-2023) and Nina Capital (2019-2023)
Holdings in the company:
- 0 shares, 1,000,000 option rights entitling the subscription of 66,666 shares
Independent from the company and major shareholders
Kustaa Poutiainen
Board member
Member of the Board since 2023
Member of the Nomination/Remuneration Committee
Born 1956
Finnish citizen
MSc in Economics from Helsinki School of Economics
Background add
Main work experience:
- Stephen Industries Inc Oy, president and chairman of the board 1992
Positions of trust:
- KP-Tekno Oy, chairman of the board
- IF Gnistan Oy, vice-chairman of the board
Holdings in the company:
- 2,206,370 shares indirectly through Stephen Industries Inc Oy
Independent from the company, but not independent from major shareholders
Michael Piccirillo
Board member
Member of the Board since 2018
Member of the Nomination/Remuneration Committee
Born 1959
Citizen of Switzerland and the United Kingdom
Education: B.Sc. Microbiology, BBA
Background add
Main work experience:
- Managing Director, VALUGEN GmbH.
- Executive Director, AO Spine and AO Trauma
- VP of surgeon education, NuVasive
- CEO of VR simulation, Symgery
Position of Trust:
- Chief Customer Engagement Officer SEeCURE,
- Member Board of Directors GSCOne
Holdings in the company:
- 10 000 shares, 1,000,000 option rights entitling the subscription of 66,666 shares.
Not independent from the company, but independent from major shareholders
Päivi Malinen
Board member
Member of the Board since 2022
Member of the Audit Committee
Member of the Nomination/Remuneration Committee
Born 1972
Finnish citizen
Education: Master of Laws LL.M., Law
Background add
Main work experience:
- Laissa Oy, partner,
- CEO of IR Partners Oy and Springvest Oyj
Positions of trust:
- Wapaaluoto Oy, board member
Holdings in the company:
- 5390 shares, 600,000 option rights entitling the subscription of 40,000 shares. Additionally 1300 shares through Wapaaluoto Oy
Independent from the company and major shareholders
Connect
Contact us© 2025 Bioretec Ltd. All rights reserved. Specifications are subject to change without notice.
Privacy Policy